The Lnk adaptor protein: A key regulator of normal and pathological hematopoiesis

Archivum Immunologiae et Therapiae Experimentalis

Volumn 60, Issue 6, 2012, Pages 415-429

  Velazquez, Laura ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Adaptor protein; Animal models; Cytokine signaling; Hematopoietic cells; Human diseases; Regulation

Indexed keywords

ADAPTOR PROTEIN; ADAPTOR PROTEIN WITH PH AND SH2 DOMAIN; CYTOKINE; PROTEIN LNK; PROTEIN SH2; PROTEIN SH2B; UNCLASSIFIED DRUG;

BONE MARROW DISEASE; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; INTRACELLULAR SIGNALING; MOLECULAR PATHOLOGY; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGENERATIVE MEDICINE; REGULATORY MECHANISM; REVIEW;

ANIMALS; CYTOKINES; HEMATOLOGIC DISEASES; HEMATOPOIESIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; SIGNAL TRANSDUCTION;

EID: 84872110844     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-012-0194-x     Document Type: Review

References (102)

1. Ahmed Z, Smith BJ, Kotani K et al (1999) APS, an adapter protein with a PH and SH2 domain, is a substrate for the insulin receptor kinase. Biochem J 341(Pt 3):665-668
2. Ahn MY, Katsanakis KD, Bheda F, Pillay TS (2004) Primary and essential role of the adaptor protein APS for recruitment of both c-Cbl and its associated protein CAP in insulin signaling. J Biol Chem 279(20):21526-21532
3. Alcina A, Vandenbroeck K, Otaegui D et al (2010) The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun 11:439-445
4. Baran-Marszak F, Magdoud H, Desterke C et al (2010) Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms. Blood 116(26):5961-5971
5. Barrès R, Gonzalez T, Le Marchand-Brustel Y, Tanti JF (2005) The interaction between the adaptor protein APS and Enigma is involved in actin organization. Exp Cell Res 308:334-344
6. Bersenev A, Wu C, Balcerek J, Tong W (2008) Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2. J. Clin. Invest. 118(8):2832-2844
7. Bersenev A, Wu C, Balcerek J et al (2010) Lnk constraints myeloproliferative diseases in mice. J. Clin. Investig 120(6): 2058-2069
8. Boulday G, Coulon F, Fraser CC et al (2002) Transcriptional upregulation of the signaling regulatory protein LNK in activated endothelial cells. Transplantation 74(9):1352-1354
9. Buza-Vidas N, Antonchuk J, Qian H et al (2006) Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK. Genes Dev 20:2018-2023
10. Calderwood DA, Huttenlocher A, Kiosses WB et al (2001) Increased filamin binding to beta-integrin cytoplasmic domains inhibits cell migration. Nat Cell Biol 3:1060-1068
11. Campbell PJ, Green AR (2008) The myeloproliferative disorders. N Engl J Med 355:2452-2466
12. Chan MP, Ilangumaran S, La Rose J et al (2003) Autoinhibition of the Kit receptor tyrosine kinase by the cytosolic juxtamembrane region. Mol Cell Biol 23:3067-3078
13. Chatelais M, Devallière J, Galli C, Charreau B (2011) Gene transfer of the adaptor Lnk (SH2B3) prevents porcine endothelial cell activation and apoptosis: implication for xenograft's cytoprotection. Xenotransplantation 18:108-120
14. Devallière J, Chatelais M, Fitau J et al (2012) LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration. FASEB. doi: 10.1096/fj.11-193383
15. Dhe-Paganon S, Werner ED, Nishi M et al (2004) Aphenylalanine zipper mediates APS dimerization. Nat Struct Mol Biol 11(10):968-974
16. Diakonova M, Gunter DR, Herrington J, Carter-Su C (2002) SH2-Bb is a Rac-binding protein that regulates cell motility. J Biol Chem 277(12):10669-10677
17. Duan C, Yang H, White MF, Rui L (2004) Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance. Mol Cell Biol 24:7435-7443
18. Ema H, Sudo K, Seita J et al (2005) Quantification of self-renewal capacity in single hematopoietic stem cells from normal and Lnk-deficient mice. Dev Cell 8:907-914
19. Enver T, Heyworth CM, Dexter TM (1998) Do stem cells play dice? Blood 92:348-351
20. Fitau J, Boulday G, Coulon F et al (2006) The adaptor molecule Lnk negatively regulates TNFα-dependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and 2 pathways. J Biol Chem 281(29):20148-20159
21. Ganesh SK, Zakai NA, Van Rooij FJA, Soranzo N et al (2009) Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet 41(11):1191-1198
22. Geest CR, Coffer PJ (2009) MAPK signaling pathways in the regulation of hematopoiesis. J. Leuk. Biol. 86:237-250
23. Gery S, Gueller S, Chumakova K et al (2007) Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders. Blood 110(9):3360-3364
24. Gery S, Qi C, Gueller S et al (2009a) Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F. J Leuk Biol. 85:957-965
25. Gery S, Gueller S, Nowak V et al (2009b) Expression of the adaptor protein Lnk in leukemia cells. Exp Hematol 37:585-592
26. Gu Y, Filippi MD, Cancelas JA et al (2003) Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science 302(5644):445-449
27. Gudbjartsson DF, Bjornsdottir US, Halapi E et al (2009) Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 41(3):342-347
28. Gueller S, Gery S, Nowak V et al (2008) Adaptor protein Lnk associates with Y568 in c-Kit. Biochem. J. 415:241-245
29. Gueller S, Goodrigde HS, Niebuhr B et al (2010) Adaptor protein Lnk inhibits c-fms-mediated macrophage function. J. Leuk. Biol. 88:699-706
30. Gueller S, Hehn S, Nowak V et al (2011) Adaptor protein Lnk binds to PDGF receptor and inhibits PDGF-dependent signaling. Exp Hematol. doi:10.1016/j.exphem.2011.02.001
31. Ha JS, Jeon DS (2011) Possible new LNK mutations in myeloproliferative neoplasms. Am J Hematol 86(10):866-868
32. He X, Li Y, Schembri-King J et al (2000) Identification of actin binding protein, ABP-280, as a binding partner of human Lnk adaptor protein. Mol Immunol 37:603-612
33. Herrington J, Diakonova M, Rui L et al (2000) SH2-B is required for Growth hormone-induced actin reorganization. J Biol Chem 275(17):13126-13133
34. Hu J, Hubbard SR (2006) Structural basis for phosphotyrosine recognition by the Src Homology-2 domains of the adapter proteins SH2-B and APS. J Mol Biol 361:69-79
35. Hu J, Liu J, Ghirlando R et al (2003) Structural basis for recruitment of the adaptor protein APS to the activated Insulin receptor. Mol Cell 12:1379-1389
36. Huang X, Li Y, Tanaka K et al (1995) Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase C1, Grb2, and phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA 92:11618-11622
37. Hunt K, Zhernakova A, Turner G et al (2008) Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 40(4):395-402
38. Hurtado C, Erquiaga I, Aranaz P et al (2011) LNK can also be mutated outside PH and SH2 domains in myeloproliferative neoplasms with and without V617FJAK2 mutation. Leuk Res 35(11):1537-1539
39. Ikram MK, Xueking S, Jensen RA et al (2010) Four novel loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo. PLoS Genet 6(10):e1001184
40. Iseki M, Kubo C, Kwon SM et al (2004) Increased numbers of B-1 cells and enhanced responses against TI-2 antigen in mice lacking APS and adaptor molecule containing PH and SH2 domains. Mol Cell Biol 24:2243-2250
41. Iseki M, Kubo-Akashi C, Kwon SM et al (2005) APS, an adaptor molecule containing PH and SH2 domains, has a negative regulatory role in B cell proliferation. Biochem. Biophys. Research. Commun. 330:1005-1013
42. Kamei N, Kwon SM, Alev C et al (2010) Lnk deletion reinforces the function of bone marrow progenitors in promoting neovascularization and astrogliosis following spinal cord injury. Stem Cells. 28(2):365-375
43. Kent DG, Dykstra BJ, Cheyne J et al (2008) Steel factor coordinately regulates the molecular signature and biologic function of hematopoietic stem cells. Blood 112:560-567
44. Khwaja A (2006) The role of Janus kinases in haemopoiesis and haematological malignancy. Br J Haematol 134:366-384
45. Kishi K, Mawatari K, Sakai-Wakamatsu K et al (2007) APS-mediated ubiquitination of the insulin receptor enhances its internalization, but does not induce its degradation. Endocrinology 54(1):77-88
46. Kubo-Akashi C, Seki M, Kwon SM et al (2004) Roles of a conserved family of adaptor proteins, Lnk, SH2-B, and APS, for mast cell development, growth, and functions: APS-deficiency causes augmented degranulation and reduced actin assembly. Biochem. Biophys. Research. Commun. 315:356-362
47. Kurzer JH, Argetsinger LS, Zhou YJ et al (2004) Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-Bβ. Mol Cell Biol 24(10):4557-4570
48. Kurzer JH, Saharinen P, Silvennoinen O, Carter-Su C (2006) Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state. Mol Cell Biol 26(17):6381-6394
49. Kwon SM, Suzuki T, Kawamoto A et al (2009) Pivotal role of Lnk adaptor protein in endothelial progenitor cell biology for vascular regeneration. Circ Res 104:969-977
50. Lasho TL, Pardanani A, Tefferi A (2010) LNK mutations in JAK2 mutation-negative erythrocytosis.NEngl JMed 363(12):1189-1190
51. Lasho TL, Tefferi A, Finke C, Pardanani A (2011) Clonal hierarchy and allelic mutation segregation in a myelofibrosis patient with two distinct LNK mutations. Leukemia. doi:10.1038/leu.2011.45
52. Lavrikova EY, Nikitin AG, Kuraeva TL et al (2011) The carriage of the type I diabetes-associated R262W variant of human LNK correlates with increased proliferation of peripheral blood monocytes in diabetic patients. Pediatr Diabetes 12(2):127-132
53. Leevers SJ, Vanhaesebroeck B, Waterfield MD (1999) Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr Opin Cell Biol 11:219-225
54. Li Y, He X, Schembri-King J et al (2000) Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation. J. Immunol. 164:5199-5206
55. Li M, Li Z, Morris DL, Rui L (2007) Identification of SH2B2β as an inhibitor for SH2B1- and SH2B2α-promoted Janus kinase-2 activation and insulin signaling. Endocrinology 148:1615-1621
56. Matsumoto T, Li M, Nishimura H et al (2010) Lnk-dependent axis of SCF-cKit signal for osteogenesis in bone fracture healing. J Exp Med 207:2207-2223
57. Moodie SA, Alleman-Sposeto J, Gustafson TA (1999) Identification of the APS protein as a novel insulin receptor substrate. J Biol Chem 274:11186-11193
58. Nelms K, O'Neill TJ, Li S et al (1999) Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. Mamm Genome 10:1160-1167
59. Nishi M, Werner ED, Oh BC et al (2005) Kinase activation through dimerization by human SH2-B. Mol Cell Biol 25:2607-2621
60. Nobuhisa I, Takizawa M, Takaki S et al (2003) Regulation of hematopoietic development in the aorta-gonad-mesonephros region mediated by Lnk adaptor protein. Mol Cell Biol 23(23):8486-8494
61. Oh ST, Simonds EF, Jones C et al (2010) Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patientswith myeloproliferative neoplasms. Blood 116(6):988-992
62. Ohtsuka S, Takaki S, Iseki M et al (2002) SH2-B is required for both male and female reproduction. Mol Cell Biol 22:3066-3077
63. Ortmann RA, Cheng T, Visconti R et al (2000) Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation. Arthritis Res 2:16-32
64. Osborne MA, Dalton S, Kochan JP (1995) The yeast tribrid system: genetic detection of trans-phosphorylated ITAM-SH2-interactions. Biotechnology 13:1474-14781
65. Pardanani A, Lasho T, Finke C et al (2010) LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations. Leukemia 24(10):1713-1718
66. Pawson T, Scott JD (1996) Signaling through scaffold, anchoring, and adaptor proteins. Science 278:2075-2080
67. Ren D, Li M, Duan C, Rui L (2005) Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice. Cell Metab 2:95-104
68. Rider L, Diakonova M (2011) Adapter protein SH2B1β binds filamin A to regulate prolactin-dependent cytoskeletal reorganization and cell motility. Mol Endocrinol 25(7):1231-1243
69. Rider L, Tao J, Snyder S et al (2009) Adapter protein SH2B1β crosslinks actin filaments and regulates actin cytoskeleton. Mol Endocrinol 23(7):1065-1076
70. Riedel H, Wang J, Hansen H, Yousaf N (1997) PSM, an insulindependent, pro-rich, PH, SH2 domain containing partner of the insulin receptor. J Biochem 122:1105-1113
71. Rudd EC (2001) Lnk adaptor: novel negative regulator of B cell lymphopoiesis. Sci STKE 2001:PE1
72. Rui L, Mathews LS, Hotta K et al (1997) Identification of SH2-Bβ as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling. Mol Cell Biol 17(11):6633-6644
73. Rui L, Gunter DR, Herrington J, Carter-Su C (2000) Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-Bβ. Mol Cell Biol 20(9):3168-3177
74. Schade AE, Wlodarski MW, Maciejewski JP (2006) Pathophysiology defined by altered signal transduction pathways. the role of JAKSTAT and PI3K signaling in leukemic large granular lymphocytes. Cell Cycle 5(22):2571-2574
75. Seita J, Ema H, Ooehara J et al (2007) Lnk negatively regulates selfrenewal of hematopoietic stem cells by modifying thrombopoietin- mediated signal transduction. Proc. Natl. Acad. Sci. USA 104(7):2349-2354
76. Simon C, Dondi E, Chaix A et al (2008) Lnk adaptor protein downregulates specific Kit-induced signaling pathways in primary mast cells. Blood 112:4039-4047
77. Soranzo N, Spector TD, Mangino M et al (2009) A genome-wide meta-analysis identifies 22 loci associated with eight haematological parameters in the HaemGen consortium. Nat Genet 41(11):1182-1190
78. Suzuki N, Yamazaki S, Ema H et al (2012): Homeostasis of hematopoietic stem cells regulated by the myeloproliferative disease associated-gene product Lnk/Sh2b3 via Bcl-xL. Exp Hematol 40:166-174.e3
79. Takaki S, Watts JD, Forbush KA et al (1997) Characterization of Lnk. An adaptor protein expressed in lymphocytes. J Biol Chem 272:14562-14570
80. Takaki S, Sauer K, Iritani BM et al (2000) Control of B cell production by the adaptor protein Lnk: definition of a conserved family of signal-modulating proteins. Immunity 13:599-609
81. Takaki S, Morita H, Tezuka Y, Takatsu K (2002) Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk. J Exp Med. 195:151-160
82. Takaki S, Tezuka Y, Sauer K et al (2003) Impaired lymphopoiesis and altered B cell subpopulations in mice overexpressing Lnk adaptor protein. J Immunol 170:703-710
83. Takizawa H, Kubo-Akashi C, Nobuhisa I et al (2006) Enhanced engraftment of hematopoietic stem/progenitor cells by the transient inhibition of an adaptor protein, Lnk. Blood 107(7):2968-2975
84. Takizawa H, Eto K, Yoshikawa A et al (2008) Growth and maturation of megakaryocytes is regulated by Lnk/SH2B3 adaptor protein through crosstalk between cytokine- and integrin-mediated signals. Exp Hematol 36(7):897-906
85. Takizawa H, Nishimura S, Takayama N et al (2010) Lnk regulates integrin aIIbβ3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivo. J. Clin. Investig 120(1):179-190
86. Tefferi A (2010) Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 24:1128-1138
87. Tong W, Lodish FH (2004) Lnk inhibits Tpo-mpl signaling and Tpomediated megakaryocytopoiesis. J Exp Med 200:569-580
88. Tong W, Zhang J, Lodish FH (2005) Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Blood 105:4604-4612
89. Velazquez L, Cheng AM, Fleming HE et al (2002) Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J Exp Med 195(12):1599-1611
90. Wakioka T, Sasaki A, Mitsui K et al (1999) APS, an adaptor protein containing pleckstrin homology (PH) and Src homology-2 (SH2) domains inhibits the JAK-STAT pathway in collaboration with c-Cbl. Leukemia 13:760-767
91. Wan M, Li Y, Xue H, Li Q, Li J (2006) TNF-α induces Lnk expression through PI3K-dependent signaling pathway in human umbilical vein endothelial cells. J. Surg. Res. 136:53-57
92. Wang TC, Chiu H, Chang YJ et al (2011) The adaptor protein SH2B3 (Lnk) negatively regulates neurite outgrowth of PC12 cells and cortical neurons. PLoS ONE 6(10):e26433
93. Ward AC, Touw I, Yoshimura A et al (2000) The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood 95:19-29
94. Watowich SS, Wu H, Socolovsky M et al (1996) Cytokine receptor signal transduction and the control of hematopoietic cell development. Annu Rev Cell Dev Biol 12:91-128
95. Werz C,Köhler K,HafenE, StockerH(2009)The DrosophilaSH2Bfamily adaptor Lnk acts in parallel to Chico in the insulin signaling pathway. PLoS Genet 5(8):e1000596. doi:10.1371/journal.pgen.1000596
96. Wollberg P, Kennartsson J, Gottridsson E et al (2003) The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit. Biochem J. 370:1033-1038
97. Yabana N, Shibuya M (2002) Adaptor protein APS binds the NH2- terminal autoinhibitory domain of guanine exchange factor Vav3 and augments its activity. Oncogene 21:7720-7729
98. Yasukawa H, Sasaki A, Yoshimura A (2000) Negative regulation of cytokine signaling pathways. Annu Rev Immunol 18:143-164
99. Yokouchi M, Suzuki R, Masuhara M et al (1997) Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation. Oncogene 15:7-15
100. Yokouchi M, Wakioka T, Sakamoto H et al (1999) APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis. Oncogene 18:759-767
101. Yousaf N, Deng Y, Kang Y, Riedel H (2001) Four PSM/SH2.B alternative splice variants and their differential roles in mitogenesis. J Biol Chem 276:40940-40948
102. Zhernalova A, Elbers CC, Ferwerda B, Romanos J et al (2010) Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am J Hum Genet 86:970-997